Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 20 and 75 years old.
- Women who need a mastectomy (surgical removal of the breast) for a specific reason, while keeping the nipple, where the cancer or abnormal tissue is more than 2 cm away from the nipple — this includes extensive pre-cancerous tissue, cancer in multiple areas of the breast, large tumours, or cases where the patient does not want breast-conserving surgery.
- Women with a smaller to medium breast size (cup size A, B, or C based on bra sizing) and with minimal to moderate breast drooping (confirm with trial site).
- Women who want to have their breast reconstructed immediately at the time of the mastectomy.
- Women who are generally well enough to undergo treatment, based on a standard health scoring system (confirm with trial site).
Who may not be able to join:
- Women whose cancer involves the skin of the breast.
- Women with inflammatory breast cancer (a type where the breast becomes red and swollen).
- Women who have previously had breast cancer surgery on the same breast.
- Women who have previously had radiation treatment to the same breast.
- Women whose breast size is large enough to require a specific type of surgical technique involving moving the nipple (confirm with trial site).
- Women who smoke 10 or more cigarettes per day.
- Women with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height).
- Women who are pregnant or breastfeeding.
- Women who are not able to give informed consent for legal or health reasons (confirm with trial site).
- Women already taking part in another clinical trial involving a medical intervention.
- Women considered to be at higher risk from anaesthesia based on a standard health scoring system (confirm with trial site).
- Women considered legally vulnerable, including those receiving psychiatric care, those without freedom of movement, or those in a health or social care institution.
- Women of childbearing age who are not using effective contraception.
- Women who are not affiliated with the French social security system.
- Women who have not provided signed, informed consent to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Success rate of endoscopic nipple sparing mastectomy (E-NSM) for breast cancer patients.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.